Atlas Trials

Study of Abiraterone Acetate in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC), Chemo-Naive, Who Received a Prior Diethylstilbestrol Therapy

Clinical trial NCT02217566 · COMPLETED

Trial details

NCT number
NCT02217566
Sponsor
Janssen Research & Development, LLC
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Prostatic Neoplasms
Start date
2014-09-23
Primary completion
2018-10-26
Enrollment
46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.